Huanzhang Li

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Medicine · Health Sciences

9h-index428citations45works3.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(15), Brain Metastases and Treatment(7), Parasitic infections in humans and animals(6), Cancer Immunotherapy and Biomarkers(5), Meningioma and schwannoma management(4)

Publications45 total

<i>TERT</i><scp>p</scp> Mutation and its Prognostic Value in Glioma Patients Under the 2021 <scp>WHO</scp> Classification: A Real‐World Study
Cancer Medicine·2025· 1 citedOpen Access
Clinical features, <scp>MRI</scp>, molecular alternations, and prognosis of astrocytoma based on <scp>WHO</scp> 2021 classification of central nervous system tumors: A single‐center retrospective study
Cancer Medicine·2024· 2 citedOpen Access
The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis
BMC Neurology·2024· 5 citedOpen Access
A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
Discover Oncology·2024· 1 citedOpen Access
Clinical roles of EGFR amplification in diffuse gliomas: a real-world study using the 2021 WHO classification of CNS tumors
Frontiers in Neuroscience·2024· 10 citedOpen Access
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification
Journal of Molecular Neuroscience·2024· 2 citedOpen Access
Novel insight into histological and molecular astrocytoma, <scp>IDH</scp>‐mutant, Grade 4 by the updated <scp>WHO</scp> classification of central nervous system tumors
Cancer Medicine·2023· 14 citedOpen Access
Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
Frontiers in Oncology·2023· 64 citedOpen Access
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
Frontiers in Neuroscience·2023· 3 citedOpen Access
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
Cell Communication and Signaling·2023· 22 citedOpen Access
Durvalumab After Chemoradiotherapy for Patients With Unresectable Stage III NSCLC: The PACIFIC-R Study
Journal of Thoracic Oncology·2023· 5 citedOpen Access
Molecular determinants of neurocognitive deficits in glioma: based on 2021 WHO classification
Research Square (Research Square)·2023· 1 citedOpen Access
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
Frontiers in Oncology·2023· 37 citedOpen Access
Management of IDH-mutant astrocytoma based on WHO 2021 classification of central nervous system tumors: a single center retrospective study
Research Square (Research Square)·2023Open Access
Durvalumab After Sequential Chemoradiotherapy Is Safe for Stage III, Unresectable NSCLC: Results From Phase 2 PACIFIC-6 Trial
Journal of Thoracic Oncology·2022· 5 cited
U–Pb geochronology and Hf isotope characterization of detrital zircons from Nanhua System of northeastern Guangxi and their constraints on the southwestern suture zone between Yangtze and Cathaysia blocks, South China
Arabian Journal of Geosciences·2022· 3 cited
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Journal of Hematology & Oncology·2022· 163 citedOpen Access
Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors
Journal of Clinical Oncology·2022· 1 cited
Bevacizumab Plus Atezolizumab in Pretreated Progressive and Metastatic NSCLC
Journal of Thoracic Oncology·2022
Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: A Bayesian network analysis
Pharmacological Research·2022· 10 cited
page 1 of 3Next →

Frequent Co-authors

Yaning Wang(15), Wenbin Ma(15), Yuekun Wang(14), Yu Wang(13), Tian Qu(13), Xiaopeng Guo(12), Wenlin Chen(12), Tianrui Yang(12), Jiaming Wu(12), Tingyu Liang(12), Qianshu Liu(12), Shanmu Jin(12), Siying Guo(12), Junlin Li(11), Kun Zhang(11), Hai Wang(9), Hao Xing(7), Yilin Li(7), Yixin Shi(7), Zang Xin-Zhong(7)